Switch to:
Also traded in: Germany

GuruFocus Financial Strength Rank measures how strong a company’s financial situation is. It is based on these factors

1. The debt burden that the company has as measured by its Interest coverage (current year).
2. Debt to revenue ratio. The lower, the better
3. Altman Z-score.

A company ranks high with financial strength is likely to withstand any business slowdowns and recessions.

Financial Strength : 4/10

vs
industry
vs
history
Cash-to-Debt 0.02
HCA's Cash-to-Debt is ranked lower than
93% of the 210 Companies
in the Global Medical Care industry.

( Industry Median: 0.26 vs. HCA: 0.02 )
Ranked among companies with meaningful Cash-to-Debt only.
HCA' s Cash-to-Debt Range Over the Past 10 Years
Min: 0.01  Med: 0.02 Max: N/A
Current: 0.02
Equity-to-Asset -0.22
HCA's Equity-to-Asset is ranked lower than
97% of the 205 Companies
in the Global Medical Care industry.

( Industry Median: 0.45 vs. HCA: -0.22 )
Ranked among companies with meaningful Equity-to-Asset only.
HCA' s Equity-to-Asset Range Over the Past 10 Years
Min: -0.5  Med: -0.22 Max: 0.39
Current: -0.22
-0.5
0.39
Interest Coverage 3.62
HCA's Interest Coverage is ranked lower than
74% of the 217 Companies
in the Global Medical Care industry.

( Industry Median: 8.17 vs. HCA: 3.62 )
Ranked among companies with meaningful Interest Coverage only.
HCA' s Interest Coverage Range Over the Past 10 Years
Min: 1.09  Med: 2.3 Max: 3.62
Current: 3.62
1.09
3.62
Piotroski F-Score: 7
Altman Z-Score: 2.17
Beneish M-Score: -2.93
WACC vs ROIC
3.40%
18.23%
WACC
ROIC
GuruFocus Profitability Rank ranks how profitable a company is and how likely the company’s business will stay that way. It is based on these factors:

1. Operating Margin
2. Trend of the Operating Margin (5-year average). The company with an uptrend profit margin has a higher rank.
••3. Consistency of the profitability
4. Piotroski F-Score
5. Predictability Rank•

The maximum rank is 10. A rank of 7 or higher means a higher profitability and may stay that way. A rank of 3 or lower indicates that the company has had trouble to make a profit.

Profitability Rank is not directly related to the Financial Strength Rank. But if a company is consistently profitable, its financial strength will be stronger.

Profitability & Growth : 8/10

vs
industry
vs
history
Operating Margin % 14.91
HCA's Operating Margin % is ranked higher than
80% of the 208 Companies
in the Global Medical Care industry.

( Industry Median: 6.49 vs. HCA: 14.91 )
Ranked among companies with meaningful Operating Margin % only.
HCA' s Operating Margin % Range Over the Past 10 Years
Min: 7.48  Med: 13.99 Max: 15.86
Current: 14.91
7.48
15.86
Net Margin % 6.97
HCA's Net Margin % is ranked higher than
67% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 4.33 vs. HCA: 6.97 )
Ranked among companies with meaningful Net Margin % only.
HCA' s Net Margin % Range Over the Past 10 Years
Min: 2.37  Med: 4.71 Max: 8.3
Current: 6.97
2.37
8.3
ROA % 8.73
HCA's ROA % is ranked higher than
80% of the 212 Companies
in the Global Medical Care industry.

( Industry Median: 3.57 vs. HCA: 8.73 )
Ranked among companies with meaningful ROA % only.
HCA' s ROA % Range Over the Past 10 Years
Min: 2.79  Med: 5.66 Max: 9.71
Current: 8.73
2.79
9.71
ROC (Joel Greenblatt) % 34.82
HCA's ROC (Joel Greenblatt) % is ranked higher than
74% of the 209 Companies
in the Global Medical Care industry.

( Industry Median: 15.74 vs. HCA: 34.82 )
Ranked among companies with meaningful ROC (Joel Greenblatt) % only.
HCA' s ROC (Joel Greenblatt) % Range Over the Past 10 Years
Min: 23.15  Med: 30.35 Max: 37.66
Current: 34.82
23.15
37.66
3-Year Revenue Growth Rate 12.30
HCA's 3-Year Revenue Growth Rate is ranked higher than
67% of the 180 Companies
in the Global Medical Care industry.

( Industry Median: 8.20 vs. HCA: 12.30 )
Ranked among companies with meaningful 3-Year Revenue Growth Rate only.
HCA' s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -7.8  Med: 9 Max: 24.3
Current: 12.3
-7.8
24.3
3-Year EBITDA Growth Rate 14.80
HCA's 3-Year EBITDA Growth Rate is ranked higher than
70% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 7.30 vs. HCA: 14.80 )
Ranked among companies with meaningful 3-Year EBITDA Growth Rate only.
HCA' s 3-Year EBITDA Growth Rate Range Over the Past 10 Years
Min: -10  Med: 8.3 Max: 39.4
Current: 14.8
-10
39.4
3-Year EPS without NRI Growth Rate 29.40
HCA's 3-Year EPS without NRI Growth Rate is ranked higher than
78% of the 131 Companies
in the Global Medical Care industry.

( Industry Median: 6.80 vs. HCA: 29.40 )
Ranked among companies with meaningful 3-Year EPS without NRI Growth Rate only.
HCA' s 3-Year EPS without NRI Growth Rate Range Over the Past 10 Years
Min: 0  Med: 12.7 Max: 88.4
Current: 29.4
0
88.4
GuruFocus has detected 3 Warning Signs with HCA Holdings Inc $HCA.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.
» HCA's 10-Y Financials

Financials


Revenue & Net Income
Cash & Debt
Operating Cash Flow & Free Cash Flow
Operating Cash Flow & Net Income

» Details

Guru Trades

Q1 2016

HCA Guru Trades in Q1 2016

Pioneer Investments 90,037 sh (New)
Jeremy Grantham 5,500 sh (New)
Lee Ainslie 369,220 sh (New)
Joel Greenblatt 622,232 sh (+151.57%)
Steven Cohen 247,800 sh (+126.72%)
Mario Gabelli 50,400 sh (+81.29%)
David Dreman 25,171 sh (+10.96%)
Larry Robbins 14,675,592 sh (+2.62%)
Jim Simons Sold Out
Louis Moore Bacon Sold Out
First Pacific Advisors Sold Out
Paul Tudor Jones Sold Out
George Soros Sold Out
Vanguard Health Care Fund 11,682,053 sh (-1.92%)
Richard Perry 2,768,000 sh (-9.63%)
David Tepper 3,173,423 sh (-30.06%)
Eaton Vance Worldwide Health Sciences Fund 1,107,100 sh (-9.29%)
» More
Q2 2016

HCA Guru Trades in Q2 2016

John Hussman 100,000 sh (New)
Jim Simons 574,500 sh (New)
Andreas Halvorsen 1,089,482 sh (New)
Paul Tudor Jones 22,420 sh (New)
Joel Greenblatt 916,670 sh (+47.32%)
Pioneer Investments 90,948 sh (+1.01%)
Vanguard Health Care Fund 11,682,053 sh (unchged)
Mario Gabelli 50,400 sh (unchged)
Richard Perry Sold Out
Lee Ainslie Sold Out
Steven Cohen Sold Out
David Dreman 25,075 sh (-0.38%)
Larry Robbins 14,586,992 sh (-0.60%)
Jeremy Grantham 3,900 sh (-29.09%)
David Tepper 1,216,940 sh (-61.65%)
Eaton Vance Worldwide Health Sciences Fund 709,300 sh (-35.93%)
» More
Q3 2016

HCA Guru Trades in Q3 2016

Glenn Greenberg 2,498,550 sh (New)
Steve Mandel 1,669,543 sh (New)
John Paulson 162,500 sh (New)
Jeremy Grantham 4,400 sh (+12.82%)
Larry Robbins 15,988,990 sh (+9.61%)
David Tepper 1,236,940 sh (+1.64%)
Vanguard Health Care Fund 11,682,053 sh (unchged)
Mario Gabelli 50,400 sh (unchged)
John Hussman Sold Out
Paul Tudor Jones Sold Out
Andreas Halvorsen Sold Out
Pioneer Investments Sold Out
David Dreman 24,263 sh (-3.24%)
Joel Greenblatt 379,392 sh (-58.61%)
Jim Simons 45,100 sh (-92.15%)
Eaton Vance Worldwide Health Sciences Fund 304,824 sh (-57.02%)
» More
Q4 2016

HCA Guru Trades in Q4 2016

John Hussman 50,000 sh (New)
First Pacific Advisors 16,500 sh (New)
Lee Ainslie 44,730 sh (New)
Paul Singer 885,000 sh (New)
Paul Tudor Jones 7,000 sh (New)
Jeremy Grantham 47,400 sh (+977.27%)
Glenn Greenberg 3,617,751 sh (+44.79%)
Larry Robbins 18,181,441 sh (+13.71%)
Vanguard Health Care Fund 12,087,883 sh (+3.47%)
Mario Gabelli 50,400 sh (unchged)
Larry Robbins 250,000 sh (unchged)
Eaton Vance Worldwide Health Sciences Fund 304,824 sh (unchged)
Jim Simons Sold Out
Steve Mandel Sold Out
David Tepper 1,145,250 sh (-7.41%)
David Dreman 19,562 sh (-19.38%)
John Paulson 111,600 sh (-31.32%)
Joel Greenblatt 116,944 sh (-69.18%)
» More
» Details

Insider Trades

Latest Guru Trades with HCA

(List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)

No Entry found in the selected group of Gurus. You can
  • 1. Modify your Personalized List of Gurus, or
  • 2. Click on Premium Premium Tools above to check out all the Gurus, or
  • 3. Click on Premium Plus Premium Plus above for the stocks picks of all the institutional investment advisors (>4000)
» Interactive Charts

Peter Lynch Chart ( What is Peter Lynch Charts )

Business Description

Industry: Health Care Providers » Medical Care    NAICS: 622110    SIC: 8062
Compare:NYSE:FMS, OTCPK:FSNUY, NYSE:DVA, NYSE:UHS, OTCPK:RMSYF, NYSE:EVHC, NAS:WOOF, OTCPK:SKHCY, NYSE:MD, OTCPK:CAKFY, NAS:ACHC, NYSE:HLS, NYSE:CHE, OTCPK:LTGHY, NAS:LPNT, NAS:SCAI, NYSE:THC, NYSE:AMN, NYSE:SEM, NAS:AMED » details
Traded in other countries:2BH.Germany,
HCA Holdings Inc is a health care services company. It operates general acute care hospitals, psychiatric hospitals; and rehabilitation hospitals. It also operates freestanding surgery centers.

HCA Holdings Inc was incorporated in Nevada in January 1990 and reincorporated in Delaware in September 1993. It is a health care services company in the United States. It operates 168 hospitals, comprised of 164 general, acute care hospitals; three psychiatric hospitals; and one rehabilitation hospital. In addition, it operates 116 freestanding surgery centers. Its facilities are located in 20 states and England. Its general, acute care hospitals typically provide services to accommodate such medical specialties as internal medicine, general surgery, cardiology, oncology, neurosurgery, orthopedics and obstetrics, as well as diagnostic and emergency services. Outpatient and ancillary health care services are provided by its general, acute care hospitals, freestanding surgery centers, diagnostic centers and rehabilitation facilities. Its psychiatric hospitals provide mental health care services through inpatient, partial hospitalization and outpatient settings. The Company is subject to various federal, state and local statutes and ordinances regulating the discharge of materials into the environment. Some competing facilities are physician-owned or are owned by tax-supported government agencies and many others are owned by not-for-profit entities that may be supported by endowments, charitable contributions and/or tax revenues and are exempt from sales, property and income taxes. It also faces competition from specialty hospitals and from both its own and unaffiliated freestanding ASCs for market share in certain high margin services.

Guru Investment Theses on HCA Holdings Inc

Bill Nygren Comments on HCA - Jan 10, 2017

HCA (NYSE:HCA) is the largest operator of for-profit hospitals and related health care services in the U.S. The company benefits from scale and size advantages, an attractive geographic footprint in higher growth markets, best-in-class management and governance, and an equity-friendly approach to capital allocation. We expect HCA to grow operating income in the mid-single digits and grow EPS in the low-double digits over time. Hospital stocks sold off following the presidential election due to concerns that the benefits from health care reform will be lost. We believe that HCA’s share price discounts the effects of repealing the Affordable Care Act. Accordingly, the shares are selling below our estimate of intrinsic value.

From Bill Nygren (Trades, Portfolio)'s Oakmark Fund fourth quarter 2016 commentary.

Check out Bill Nygren latest stock trades

Top Ranked Articles about HCA Holdings Inc

Bill Nygren Comments on HCA Guru stock highlight
HCA (NYSE:HCA) is the largest operator of for-profit hospitals and related health care services in the U.S. The company benefits from scale and size advantages, an attractive geographic footprint in higher growth markets, best-in-class management and governance, and an equity-friendly approach to capital allocation. We expect HCA to grow operating income in the mid-single digits and grow EPS in the low-double digits over time. Hospital stocks sold off following the presidential election due to concerns that the benefits from health care reform will be lost. We believe that HCA’s share price discounts the effects of repealing the Affordable Care Act. Accordingly, the shares are selling below our estimate of intrinsic value. Read more...
Glenn Greenberg Gains 3 Positions in the 3rd Quarter Guru invests in health care, technology and telecommunications
Brave Warrior Advisors’ Glenn Greenberg (Trades, Portfolio) purchased three new holdings in the third quarter. They are HCA Holdings Inc. (NYSE:HCA), Sensata Technologies Holding NV (NYSE:ST) and LiLAC Group (NASDAQ:LILAK). Read more...
David Tepper Exits Facebook, Boosts Allergan Guru's second quarter trades
David Tepper (Trades, Portfolio) is the founder of Appaloosa Management, which is a $3 billion hedge fund investment firm based in Chatham, New Jersey. The following are his largest trades of the second quarter. Read more...
Richard Perry Sells HCA Holdings, AIG Guru's largest 2nd quarter trades
Richard Perry (Trades, Portfolio) co-founded private investment management firm Perry Capital LLC in 1988, which manages about $14 billion as of August 2008. During the second quarter, the company traded the following stocks. Read more...
John Hussman Buys Infosys, Southern The guru's largest 2nd-quarter acquisitions
John Hussman (Trades, Portfolio) is the president and principal shareholder of Hussman Strategic Advisors, the investment advisory firm that manages the Hussman Funds. During the second quarter he bought shares in the following stocks. Read more...
Richard Perry Trims Time Warner, AIG The guru's largest 1st-quarter transactions
Richard Perry (Trades, Portfolio) co-founded private investment management firm Perry Capital LLC in 1988, which manages about $14 billion as of August 2008. The following are his largest deals during the first quarter: Read more...
All-In-One Screener Finds Week's Largest Insider Trades A recap of the most important transactions
The All-in-One Screener can be used to find insider buys and sells over the last week by clicking on the Insiders tab and changing the settings for All Insider Buying to “$1,000,000+” and duration to "May 2016.” Read more...
John Paulson Trims Stake in Allergan, Time Warner Cable Event-driven investor's top 4th quarter trades
John Paulson (Trades, Portfolio) established Paulson & Co. Inc. as a merger arbitrage hedge fund manager, seeking to make money from situations when one public company announces plans to take over another. During the fourth quarter, he sold many stocks including the following. Read more...
John Paulson Sells Allergan, Precision Castparts, AIG Top sales by the investor during the 4th quarter
John Paulson (Trades, Portfolio) is the president and portfolio manager of Paulson & Co. Inc. Paulson was ranked by Absolute Return Magazine as the third-largest hedge fund in the world managing approximately $29 billion in merger, event and distressed strategies. The following are the guru's largest sales during the fourth quarter of 2015. Read more...

Ratios

vs
industry
vs
history
PE Ratio 12.04
HCA's PE Ratio is ranked higher than
88% of the 160 Companies
in the Global Medical Care industry.

( Industry Median: 25.10 vs. HCA: 12.04 )
Ranked among companies with meaningful PE Ratio only.
HCA' s PE Ratio Range Over the Past 10 Years
Min: 4.08  Med: 13.58 Max: 19.67
Current: 12.04
4.08
19.67
Forward PE Ratio 11.90
HCA's Forward PE Ratio is ranked higher than
88% of the 69 Companies
in the Global Medical Care industry.

( Industry Median: 19.72 vs. HCA: 11.90 )
Ranked among companies with meaningful Forward PE Ratio only.
N/A
PE Ratio without NRI 12.04
HCA's PE Ratio without NRI is ranked higher than
91% of the 159 Companies
in the Global Medical Care industry.

( Industry Median: 25.91 vs. HCA: 12.04 )
Ranked among companies with meaningful PE Ratio without NRI only.
HCA' s PE Ratio without NRI Range Over the Past 10 Years
Min: 4.08  Med: 13.58 Max: 19.67
Current: 12.04
4.08
19.67
Price-to-Owner-Earnings 10.28
HCA's Price-to-Owner-Earnings is ranked higher than
86% of the 95 Companies
in the Global Medical Care industry.

( Industry Median: 27.14 vs. HCA: 10.28 )
Ranked among companies with meaningful Price-to-Owner-Earnings only.
HCA' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 6.27  Med: 11.96 Max: 58.95
Current: 10.28
6.27
58.95
PS Ratio 0.85
HCA's PS Ratio is ranked higher than
73% of the 206 Companies
in the Global Medical Care industry.

( Industry Median: 1.46 vs. HCA: 0.85 )
Ranked among companies with meaningful PS Ratio only.
HCA' s PS Ratio Range Over the Past 10 Years
Min: 0.32  Med: 0.67 Max: 1.07
Current: 0.85
0.32
1.07
Price-to-Free-Cash-Flow 12.08
HCA's Price-to-Free-Cash-Flow is ranked higher than
82% of the 94 Companies
in the Global Medical Care industry.

( Industry Median: 23.37 vs. HCA: 12.08 )
Ranked among companies with meaningful Price-to-Free-Cash-Flow only.
HCA' s Price-to-Free-Cash-Flow Range Over the Past 10 Years
Min: 4.19  Med: 11.46 Max: 17.22
Current: 12.08
4.19
17.22
Price-to-Operating-Cash-Flow 6.18
HCA's Price-to-Operating-Cash-Flow is ranked higher than
87% of the 135 Companies
in the Global Medical Care industry.

( Industry Median: 13.84 vs. HCA: 6.18 )
Ranked among companies with meaningful Price-to-Operating-Cash-Flow only.
HCA' s Price-to-Operating-Cash-Flow Range Over the Past 10 Years
Min: 2.58  Med: 5.7 Max: 8.53
Current: 6.18
2.58
8.53
EV-to-EBIT 9.99
HCA's EV-to-EBIT is ranked higher than
93% of the 145 Companies
in the Global Medical Care industry.

( Industry Median: 19.61 vs. HCA: 9.99 )
Ranked among companies with meaningful EV-to-EBIT only.
HCA' s EV-to-EBIT Range Over the Past 10 Years
Min: 6.3  Med: 10.7 Max: 12.6
Current: 9.99
6.3
12.6
EV-to-EBITDA 7.68
HCA's EV-to-EBITDA is ranked higher than
90% of the 157 Companies
in the Global Medical Care industry.

( Industry Median: 14.11 vs. HCA: 7.68 )
Ranked among companies with meaningful EV-to-EBITDA only.
HCA' s EV-to-EBITDA Range Over the Past 10 Years
Min: 5  Med: 7.9 Max: 9.4
Current: 7.68
5
9.4
PEG Ratio 1.41
HCA's PEG Ratio is ranked higher than
79% of the 85 Companies
in the Global Medical Care industry.

( Industry Median: 2.76 vs. HCA: 1.41 )
Ranked among companies with meaningful PEG Ratio only.
HCA' s PEG Ratio Range Over the Past 10 Years
Min: 0.74  Med: 2.34 Max: 6.45
Current: 1.41
0.74
6.45
Shiller PE Ratio 18.31
HCA's Shiller PE Ratio is ranked higher than
82% of the 45 Companies
in the Global Medical Care industry.

( Industry Median: 30.81 vs. HCA: 18.31 )
Ranked among companies with meaningful Shiller PE Ratio only.
HCA' s Shiller PE Ratio Range Over the Past 10 Years
Min: 6.14  Med: 13.2 Max: 23.02
Current: 18.31
6.14
23.02
Current Ratio 1.56
HCA's Current Ratio is ranked higher than
64% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 1.20 vs. HCA: 1.56 )
Ranked among companies with meaningful Current Ratio only.
HCA' s Current Ratio Range Over the Past 10 Years
Min: 1.2  Med: 1.52 Max: 1.7
Current: 1.56
1.2
1.7
Quick Ratio 1.30
HCA's Quick Ratio is ranked higher than
61% of the 201 Companies
in the Global Medical Care industry.

( Industry Median: 1.07 vs. HCA: 1.30 )
Ranked among companies with meaningful Quick Ratio only.
HCA' s Quick Ratio Range Over the Past 10 Years
Min: 1.08  Med: 1.34 Max: 1.51
Current: 1.3
1.08
1.51
Days Inventory 77.30
HCA's Days Inventory is ranked lower than
88% of the 156 Companies
in the Global Medical Care industry.

( Industry Median: 16.39 vs. HCA: 77.30 )
Ranked among companies with meaningful Days Inventory only.
HCA' s Days Inventory Range Over the Past 10 Years
Min: 57.16  Med: 68.53 Max: 77.44
Current: 77.3
57.16
77.44
Days Sales Outstanding 51.25
HCA's Days Sales Outstanding is ranked lower than
63% of the 170 Companies
in the Global Medical Care industry.

( Industry Median: 44.02 vs. HCA: 51.25 )
Ranked among companies with meaningful Days Sales Outstanding only.
HCA' s Days Sales Outstanding Range Over the Past 10 Years
Min: 44.84  Med: 52.29 Max: 56.3
Current: 51.25
44.84
56.3
Days Payable 122.04
HCA's Days Payable is ranked higher than
79% of the 131 Companies
in the Global Medical Care industry.

( Industry Median: 38.57 vs. HCA: 122.04 )
Ranked among companies with meaningful Days Payable only.
HCA' s Days Payable Range Over the Past 10 Years
Min: 108.24  Med: 112.98 Max: 122.04
Current: 122.04
108.24
122.04

Buy Back

vs
industry
vs
history
5-Year Yield-on-Cost % 0.30
HCA's 5-Year Yield-on-Cost % is ranked lower than
96% of the 304 Companies
in the Global Medical Care industry.

( Industry Median: 2.28 vs. HCA: 0.30 )
Ranked among companies with meaningful 5-Year Yield-on-Cost % only.
HCA' s 5-Year Yield-on-Cost % Range Over the Past 10 Years
Min: 0  Med: 0 Max: 0
Current: 0.3
3-Year Average Share Buyback Ratio 5.50
HCA's 3-Year Average Share Buyback Ratio is ranked higher than
96% of the 123 Companies
in the Global Medical Care industry.

( Industry Median: -2.50 vs. HCA: 5.50 )
Ranked among companies with meaningful 3-Year Average Share Buyback Ratio only.
HCA' s 3-Year Average Share Buyback Ratio Range Over the Past 10 Years
Min: -4.1  Med: 3.4 Max: 12
Current: 5.5
-4.1
12

Valuation & Return

vs
industry
vs
history
Price-to-Intrinsic-Value-Projected-FCF 1.47
HCA's Price-to-Intrinsic-Value-Projected-FCF is ranked higher than
60% of the 96 Companies
in the Global Medical Care industry.

( Industry Median: 1.76 vs. HCA: 1.47 )
Ranked among companies with meaningful Price-to-Intrinsic-Value-Projected-FCF only.
HCA' s Price-to-Intrinsic-Value-Projected-FCF Range Over the Past 10 Years
Min: 1.23  Med: 3.7 Max: 17.85
Current: 1.47
1.23
17.85
Price-to-Median-PS-Value 1.25
HCA's Price-to-Median-PS-Value is ranked lower than
61% of the 179 Companies
in the Global Medical Care industry.

( Industry Median: 1.04 vs. HCA: 1.25 )
Ranked among companies with meaningful Price-to-Median-PS-Value only.
HCA' s Price-to-Median-PS-Value Range Over the Past 10 Years
Min: 0.55  Med: 1.01 Max: 1.34
Current: 1.25
0.55
1.34
Price-to-Peter-Lynch-Fair-Value 1.80
HCA's Price-to-Peter-Lynch-Fair-Value is ranked higher than
57% of the 46 Companies
in the Global Medical Care industry.

( Industry Median: 2.32 vs. HCA: 1.80 )
Ranked among companies with meaningful Price-to-Peter-Lynch-Fair-Value only.
HCA' s Price-to-Peter-Lynch-Fair-Value Range Over the Past 10 Years
Min: 0.86  Med: 1.54 Max: 2.25
Current: 1.8
0.86
2.25
Earnings Yield (Greenblatt) % 9.97
HCA's Earnings Yield (Greenblatt) % is ranked higher than
95% of the 185 Companies
in the Global Medical Care industry.

( Industry Median: 4.10 vs. HCA: 9.97 )
Ranked among companies with meaningful Earnings Yield (Greenblatt) % only.
HCA' s Earnings Yield (Greenblatt) % Range Over the Past 10 Years
Min: 8  Med: 9.4 Max: 16
Current: 9.97
8
16
Forward Rate of Return (Yacktman) % 12.84
HCA's Forward Rate of Return (Yacktman) % is ranked higher than
61% of the 116 Companies
in the Global Medical Care industry.

( Industry Median: 10.28 vs. HCA: 12.84 )
Ranked among companies with meaningful Forward Rate of Return (Yacktman) % only.
HCA' s Forward Rate of Return (Yacktman) % Range Over the Past 10 Years
Min: 9  Med: 13.2 Max: 17.6
Current: 12.84
9
17.6

More Statistics

Revenue (TTM) (Mil) $41,490
EPS (TTM) $ 7.32
Beta0.08
Short Percentage of Float4.83%
52-Week Range $67.00 - 87.97
Shares Outstanding (Mil)370.15

Analyst Estimate

Dec17 Dec18 Dec19
Revenue (Mil $) 45,914 49,381 52,683
EPS ($) 7.27 8.13 9.30
EPS without NRI ($) 7.27 8.13 9.30
EPS Growth Rate
(Future 3Y To 5Y Estimate)
11.95%
Dividends per Share ($)
» More Articles for HCA

Headlines

Articles On GuruFocus.com
Bill Nygren Comments on HCA Jan 10 2017 
Michael Burry and HCA Holdings Dec 16 2016 
Michael Burry: Current Holdings and a Change of Style Dec 09 2016 
Glenn Greenberg Gains 3 Positions in the 3rd Quarter Dec 05 2016 
Dr. Michael Burry of 'The Big Short' Buys Coty and Further Slims Portfolio Dec 01 2016 
Can Universal Health Services Power Past the Political Turbulence? Nov 30 2016 
What to Buy Now That Donald Trump Is President-elect Nov 11 2016 
David Tepper Exits Facebook, Boosts Allergan Aug 31 2016 
The Big 3: Larry Robbins' Top 2nd-Quarter Buys Aug 16 2016 
John Hussman Buys Infosys, Southern Aug 12 2016 

More From Other Websites
Universal Health (UHS) Beats on Q4 Earnings, Gives '17 View Mar 01 2017
HCA HOLDINGS, INC. Financials Feb 28 2017
4 Reasons Why HCA Holdings (HCA) is an Attractive Choice Feb 28 2017
The Zacks Analyst Blog Highlights: BioTelemetry, WellCare Health Plans, Joint, HCA Holdings and... Feb 28 2017
5 Stocks to Buy for the Post-Obamacare Era Feb 27 2017
[$$] Shop Talk: Bain Capital's Chris Gordon and QuVa Pharma's Stuart Hinchen on Rebuilding the Drug... Feb 27 2017
HCA HOLDINGS, INC. Files SEC form 10-K, Annual Report Feb 22 2017
Brandon Regional Hospital takes wraps off bigger ER Feb 22 2017
Ultimate Stock-Pickers: Top 10 High-Conviction and New-Money Purchases Feb 22 2017
Moody's Jumps into Action as Aetna-Humana Deal Fails Feb 17 2017
One of Wall Street's top equity analysts reveals his 4 favorite areas in the market Feb 17 2017
HCA HOLDINGS, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Creation of a... Feb 15 2017
U.S. hospital stocks start 2017 strong as some Obamacare fears ease Feb 15 2017
Moving Average Crossover Alert: HCA Holdings (HCA) Feb 15 2017
Memorial Hermann exec joins another major local hospital system Feb 09 2017
Nurse brings $6.5M retaliation lawsuit against St. Petersburg hospital and HCA Feb 06 2017
Facebook Could Stay Explosive Feb 06 2017
HCA plans nearly $3 billion in capital investments in 2017 Feb 01 2017
Edited Transcript of HCA earnings conference call or presentation 31-Jan-17 3:00pm GMT Jan 31 2017
HCA, health care foundation settle seven-year lawsuit Jan 31 2017

Personalized Checklist

Checklist has been moved to "Checklist" tab.

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)